Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Singh & Associates ordered by Published Date Descending.
Links to Result pages
1 2 3 4  
FDA Approves Balversa, A First Targeted Therapy For Metastatic Bladder Cancer
On April 12, 2019, the USFDA granted accelerated approval to Balversa (erdafitinib), a treatment for adult patients with locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration ...
United States
20 May 2019
ICMR Licenses Shigella Vaccine Technology To Hilleman Laboratories
On April 23, 2019, Indian Council of Medical Research (ICMR) licensed the technology for Shigella vaccine for further scaling up and commercialisation to MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
17 May 2019
European Commission Approval To Rituximab Is First Biologic Treatment For A Rare Autoimmune Disease
These cells are central to many blood cancers, including common forms of lymphoma and leukaemia.
European Union
17 Apr 2019
USFDA Approves First And Only Treatment For A Type Of Inflammatory Arthritis
This is the first and only treatment for nraxSpA approved by USFDA.
17 Apr 2019
Government Proposes Second Draft Amendment Of Clinical Establishment Rules, 2019
Reported draft notification on revised Rules is based on recommendations of a panel set up by the ministry on August 04, 2018.
16 Apr 2019
EMA Publishes New Guidelines For Certain Medical Devices
On February 28, 2019, European Medicine Agency published the first guidance on new rules for certain medical devices - the first of a series of guidance documents to help applicants to prepare for compliance with these new rules.
European Union
19 Mar 2019
Centre Has Drafted The First Regulatory Guidelines For Evaluation Of Nano-Pharmaceuticals In India
In February 2019, the Government of India introduced first draft regulatory guidelines for evaluation of nanopharmaceutical products for therapeutic use in the country.
19 Mar 2019
Cosmetics Manufacturers May Submit Product Composition Details Before Licensing Their Products
Central Government, in order to enhance the safety of the cosmetic products, has proposed the product composition details clause shall be mentioned in the approval issued by the licensing authority in the country.
19 Mar 2019
DoP Proposes Mandatory Quality Control Orders (QCOs) For Certain Medical Devices
On February 15, 2019, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers issued six draft QCOs, after consulting with the Bureau of Indian Standards to ensure safety and effectiveness of these medical devices:
18 Mar 2019
Central Government Notifies All Implantable Devices As Drugs
On February 08, 2019, the Central Government announced that all Implantable Medical Devices along with CT scan Equipment, MRI Equipment, Defibrillators, Dialysis Machine, PET Equipment, X-Ray Machine, and ...
18 Mar 2019
Delhi HC Quashes Ban On Wockhardt's Anti-Inflammatory Drug
The Delhi High Court, on January 01, 2019, set aside the Central Government's ban on Wockhardt's anti-inflammatory medicine ‘Ace Proxyvon', a Fixed Dose combination of Aceclofenac 100 mg, Paracetamol 325 mg ...
21 Feb 2019
Government Constitutes NITI-led Committee To Monitor Pricing Of Drugs
The Central Government, with an aim to offer medicines/healthcare products at affordable prices to the public, has taken a number of measures ranging from making drugs available through Jan Aushadhi stores ...
20 Feb 2019
The DNA Technology (Use And Application) Regulation Bill 2019
In a landmark decision, the Lok Sabha, on January 08, 2019, passed the "DNA Technology (Use and Application) Regulation Bill - 20193" (here after referred as "Bill").
20 Feb 2019
Patent Licensing
A patent is a right granted to the owner to stop others from using his invention without his consent for making, using, selling or offering for sale his patent.
21 Dec 2018
FDA Approval To Larotrectinib Is The First Treatment To Receive A Tumor-Agnostic Indication
Larotrectinib, is a CNS active TRK inhibitor designed to inhibit these proteins.
13 Dec 2018
NPPA Updates For The Month Of November 2018
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
12 Dec 2018
India's Tryst With "Evergreening" – An Ongoing Battle.
Evergreening is the term used for legal and technological alternatives adopted by Pharmaceutical companies to extend their exclusivity of over production and sale of patented medicines...
7 Dec 2018
Biotechnology Patent And Related Moral Issues
Biotechnology inventions are important for human development. It is the broad area of biology involving living systems and organisms to develop or make products, or any technological application ...
26 Nov 2018
After Banning Manufacturing, Sale And Distribution Of Antibody Detecting Rapid Diagnostic Tests For The Diagnosis Of Malaria, The Health Ministry Now Bans Its Import Too
On October 30, 2018, the Ministry of Health and Family Welfare (MoHFW) banned the import of Antibody Detecting Rapid Diagnostic Tests (ADRDTs) used for routine diagnosis of Malaria.
22 Nov 2018
Links to Result pages
1 2 3 4